These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2665845)

  • 1. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY; Norman AW; Lübbert M; Collins ED; Uskokovic MR; Koeffler HP
    Blood; 1989 Jul; 74(1):82-93. PubMed ID: 2665845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
    Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
    Zhou JY; Norman AW; Akashi M; Chen DL; Uskokovic MR; Aurrecoechea JM; Dauben WG; Okamura WH; Koeffler HP
    Blood; 1991 Jul; 78(1):75-82. PubMed ID: 1648977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS; Farsoudi KH; Peterlik M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):105-10. PubMed ID: 8446178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
    Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
    Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
    Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
    Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
    J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F; Mayer E; Norman AW
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
    Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
    Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
    Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
    Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
    J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.